title: Severe toxoplasmosis in immunocompetent hosts: be aware of atypical strains.
authors.forename: Vincent
authors.initials: V
authors.lastname: Sobanski
authors.forename: Daniel
authors.initials: D
authors.lastname: Ajzenberg
authors.forename: Laurence
authors.initials: L
authors.lastname: Delhaes
authors.forename: Nathalie
authors.initials: N
authors.lastname: Bautin
authors.forename: Nicolas
authors.initials: N
authors.lastname: Just
mesh_terms: D000981:Antiprotozoal Agents / Q000627:therapeutic use; D004417:Dyspnea / Q000209:etiology; D005334:Fever / Q000209:etiology; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D008875:Middle Aged; D011739:Pyrimethamine / Q000627:therapeutic use; D012720:Severity of Illness Index; D013546:Sweating; D014122:Toxoplasma / Q000302:isolation & purification; D014123:Toxoplasmosis / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome; D015431:Weight Loss
chemical_list: D000981:Antiprotozoal Agents; D011739:Pyrimethamine